StreetInsider.com News Articles

CDT Equity notes Sarborg fundraise, values its stake at $127.5M

Thu, 18 Jun 2026 08:30:11 -0400

CDT Equity Inc. (Nasdaq: CDT) has acknowledged a fundraising round completed by Sarborg Limited, in which a New York-based private investment fund subscribed to shares at $125,000 per share, implying a fully diluted valuation of approximately $638.3 million for Sarborg.

CDT currently holds 1,020 shares in Sarborg. Based on the price paid by the latest investor, the company said its shareholding implies a value of $127.5 million.

According to Sarborg, proceeds from the fundraise will be used to launch SarborgQ, a newly formed quantum computing division, as well as to expand proprietary datasets, accelerate intellectual property generation, and continue development of its

CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing

Thu, 18 Jun 2026 08:30:00 -0400

NAPLES, Fla. and CAMBRIDGE, United Kingdom, June 18, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding its recent fundraise from a New York-based private investment fund.

According to Sarborg, the subscription was completed at a consideration per share of $125,000, implying a fully diluted valuation of approximately $638.3 million. The proceeds will be used to support the launch and development of SarborgQ, Sarborg’s newly formed quantum computing division, alongside continued expansion of the Company’s proprietary datasets, acceleration of intellectual property generation, support of

CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing

Thu, 18 Jun 2026 08:30:00 -0400

CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing

Thu, 18 Jun 2026 08:30:00 -0400

CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing

Thu, 18 Jun 2026 08:30:00 -0400

Form 8-K CDT Equity Inc. For: Jun 11

Tue, 16 Jun 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260616/26655055.html

Form 8-K CDT Equity Inc. For: Jun 11

Tue, 16 Jun 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260616/26655055.html

CDT Equity restructures debt, secures $1.46M loan facility

Tue, 16 Jun 2026 08:33:11 -0400

CDT Equity Inc. (NASDAQ: CDT) announced it has repaid all outstanding amounts under two existing loan agreements and entered into a new loan facility of up to $1,460,000 with JJ Astor & Co., according to a press release.

The company repaid a convertible loan note originally issued to Alliance Global Partners in December 2024, which carried a principal amount of $5,737,500. CDT also repaid $555,555.56 in principal under a promissory note with Ascent Partners, entered into on March 3, 2026. The combined repayments eliminate more than $6.3 million in debt from the company's balance sheet.

On June 11, 2026, CDT entered into

CDT Equity Announces Debt Update and New Loan Facility

Tue, 16 Jun 2026 08:30:00 -0400

NAPLES, Fla. and CAMBRIDGE, United Kingdom, June 16, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced that it has re-structured its debt, agreeing to pay off all outstanding amounts due under its Loan Notes with Alliance Global Partners (“A.G.P.”) and Ascent Partners, and entering into a new Loan Agreement with JJ Astor for up to $1,460,000.

The A.G.P. Convertible Loan Note originally entered into in December 2024, had a principal amount of $5,737,500, which was repaid in full as of the beginning of June. In addition, the Company

CDT Equity Announces Debt Update and New Loan Facility

Tue, 16 Jun 2026 08:30:00 -0400

The A.G.P. Convertible Loan Note originally entered into in December 2024, had a principal amount of $5,737,500, which was repaid in full as of the beginning of June. In addition, the Company

CDT Equity Announces Debt Update and New Loan Facility

Tue, 16 Jun 2026 08:30:00 -0400

The A.G.P. Convertible Loan Note originally entered into in December 2024, had a principal amount of $5,737,500, which was repaid in full as of the beginning of June. In addition, the Company

CDT Equity Announces Debt Update and New Loan Facility

Tue, 16 Jun 2026 08:30:00 -0400

The A.G.P. Convertible Loan Note originally entered into in December 2024, had a principal amount of $5,737,500, which was repaid in full as of the beginning of June. In addition, the Company

Form SCHEDULE 13G CDT Equity Inc. Filed by: Ascent Partners Fund LLC

Fri, 05 Jun 2026 20:52:00 -0400

si-local-file:///var/storage/secattach/20260605/26612743.html

Form SCHEDULE 13G CDT Equity Inc. Filed by: Ascent Partners Fund LLC

Fri, 05 Jun 2026 20:52:00 -0400

si-local-file:///var/storage/secattach/20260605/26612743.html

Form 8-K CDT Equity Inc. For: May 21

Thu, 28 May 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260528/26567931.html

Form 8-K CDT Equity Inc. For: May 21

Thu, 28 May 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260528/26567931.html

CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter

Thu, 28 May 2026 16:15:00 -0400

NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 28, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced that the Company received a written notice (“Notice”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on May 21, 2026 indicating that the Company did not timely file its Quarterly Report on Form 10-Q for the three-month period ended March 31, 2026 (the “Form 10-Q”), as required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5250(c)(1) (the “Periodic Filing Requirement”). The Notice does not

CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter

Thu, 28 May 2026 16:15:00 -0400

CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter

Thu, 28 May 2026 16:15:00 -0400

CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter

Thu, 28 May 2026 16:15:00 -0400

CDT receives Canadian patent for AZD5904 male infertility treatment

Wed, 27 May 2026 08:01:55 -0400

CDT Equity Inc. (NASDAQ: CDT) announced that Canada has granted a patent covering the use of AZD5904 for male infertility treatment. The approval completes patent coverage for the compound across key pharmaceutical markets globally.

The company stated that this geographical patent coverage, combined with its composition of matter application, establishes intellectual property protection for AZD5904 development as it pursues licensing and strategic partnership opportunities.

AZD5904 was originally licensed from AstraZeneca and includes clinical safety data and pre-clinical validation for male infertility applications. The compound targets an area where no approved drug therapies currently exist specifically for male infertility.

"Globally, the male infertility market

CDT Announces Canadian Patent for AZD5904 in Male Infertility

Wed, 27 May 2026 08:00:00 -0400

NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 27, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announces that the patent covering the use of AZD5904 in male infertility has now been granted in Canada, completing the approval of this patent in all key pharmaceutical target markets.

CDT believes that the extensive geographical coverage of this patent combined with its more recent composition of matter application provides a strong IP position for development of AZD5904 in male infertility as discussions continue regarding potential licensing and strategic partnering opportunities.

Originally licensed from

CDT Announces Canadian Patent for AZD5904 in Male Infertility

Wed, 27 May 2026 08:00:00 -0400

Originally licensed from

CDT Announces Canadian Patent for AZD5904 in Male Infertility

Wed, 27 May 2026 08:00:00 -0400

Originally licensed from

CDT Announces Canadian Patent for AZD5904 in Male Infertility

Wed, 27 May 2026 08:00:00 -0400

Originally licensed from